Voyageur Pharmaceuticals (CVE:VM) Stock Price Down 20.8% – Time to Sell?

Voyageur Pharmaceuticals Ltd. (CVE:VM)’s stock price was down 20.8% during mid-day trading on Wednesday . The company traded as low as C$0.19 and last traded at C$0.19. Approximately 696,945 shares were traded during trading, an increase of 39% from the average daily volume of 500,773 shares. The stock had previously closed at C$0.24.

Voyageur Pharmaceuticals Stock Down 31.3 %

The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The company has a market capitalization of C$23.01 million, a PE ratio of -16.50 and a beta of 0.32. The company’s fifty day moving average is C$0.10 and its 200-day moving average is C$0.07.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.